FAQs for REM8 Antibody Research
Curated by an experienced research assistant with 15+ years in antibody validation and translational studies
Advanced Research Questions
How to resolve contradictory REM8 localization data between immunofluorescence and Western blot?
-
Stepwise approach:
-
Verify fixation/permeabilization protocols match antigen accessibility requirements
-
Compare subcellular fractionation blots with whole-cell lysates
-
Perform proximity ligation assays to confirm spatial relationships
Key consideration: Post-translational modifications may alter epitope availability in different cellular compartments .
What orthogonal methods confirm REM8 antibody target engagement in live cells?
-
Combine with:
-
Surface plasmon resonance (KD measurements)
-
Native SEC-MS for complex stability analysis
-
Phage display mutagenesis to map epitope-paratope interactions
Data correlation matrix:
| Method | Throughput | Resolution | Required Sample |
|---|
| SPR | Low | 0.1 nM | 50-100 μg |
| Hydrogen-deuterium MS | Medium | 5-10 Å | 200 μg |
| Cryo-EM | High | 3-4 Å | 1 mg |
How to design longitudinal studies tracking REM8 antibody pharmacokinetics?
-
Critical parameters:
-
Sample collection timing aligned with predicted IgG half-life (21-28 days)
-
Dual detection systems (e.g., anti-idiotype ELISA + neutralizing assays)
-
Baseline normalization against pre-immunization samples
Methodological Challenges
Standardizing REM8 antibody lot-to-lot variability in multicenter trials
-
Implement:
-
ISO/IEC 17025 compliant testing for binding kinetics
-
Accelerated stability studies (40°C/75% RH for 3 months equivalent to 2 years)
-
Consensus scoring of histopathology slides by ≥3 blinded pathologists
Analyzing REM8 cross-reactivity with homologous proteins
-
Recommended workflow:
-
Phylogenetic analysis of target protein family
-
Peptide microarray screening against all human paralogs
-
Molecular dynamics simulations of antibody-antigen complexes